Floatz logo

TENOFOVIR BIS(ISOPROPYLOXYCARBONYLOXYMETHYL) ESTER

Hepatitis B, Chronic

Qing XIeSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Hepatitis B, Chronic cohort.

Asset / SponsorPhaseRating
Entecavir
Beijing Continent Pharmaceutical Co, Ltd.
Phase 4BBB
Lamivudine
Yonsei University
Phase 4BBB
TENOFOVIR DISOPROXIL FUMARATE
Ningbo No.2 Hospital
Phase 4BBB
Telbivudine
The Fifth People's Hospital of Suzhou
Phase 4BBB
Tenofovir Alafenamide
Ningbo No.2 Hospital
Phase 4BB

View all 29 →

Same molecule, other indications

TENOFOVIR BIS(ISOPROPYLOXYCARBONYLOXYMETHYL) ESTER is also rated in:

hepatitis B virus infectionDormant
BB
Indicative ·
70 / 100
View asset →
osteoporosisDormant
BB
Indicative ·
65 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →